These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11522385)

  • 41. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
    Zachara NE; Hart GW
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells.
    Lund PJ; Elias JE; Davis MM
    J Immunol; 2016 Oct; 197(8):3086-3098. PubMed ID: 27655845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux.
    Taylor RP; Geisler TS; Chambers JH; McClain DA
    J Biol Chem; 2009 Feb; 284(6):3425-32. PubMed ID: 19073609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
    Hahne H; Gholami AM; Kuster B
    Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis.
    Wang Z; Udeshi ND; Slawson C; Compton PD; Sakabe K; Cheung WD; Shabanowitz J; Hunt DF; Hart GW
    Sci Signal; 2010 Jan; 3(104):ra2. PubMed ID: 20068230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.
    Vaidyanathan K; Durning S; Wells L
    Crit Rev Biochem Mol Biol; 2014; 49(2):140-163. PubMed ID: 24524620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
    Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
    Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
    Kim S; Maynard JC; Sasaki Y; Strickland A; Sherman DL; Brophy PJ; Burlingame AL; Milbrandt J
    J Neurosci; 2016 Sep; 36(37):9633-46. PubMed ID: 27629714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch.
    Ande SR; Moulik S; Mishra S
    PLoS One; 2009; 4(2):e4586. PubMed ID: 19238206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role and potential mechanism of O-Glycosylation in gastrointestinal tumors.
    Zhou F; Ma J; Zhu Y; Wang T; Yang Y; Sun Y; Chen Y; Song H; Huo X; Zhang J
    Pharmacol Res; 2022 Oct; 184():106420. PubMed ID: 36049664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. O-GlcNAc: a regulatory post-translational modification.
    Wells L; Whelan SA; Hart GW
    Biochem Biophys Res Commun; 2003 Mar; 302(3):435-41. PubMed ID: 12615051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanisms of O-GlcNAcylation.
    Hurtado-Guerrero R; Dorfmueller HC; van Aalten DM
    Curr Opin Struct Biol; 2008 Oct; 18(5):551-7. PubMed ID: 18822376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of novel O-GlcNAc transferase substrates using yeast cells expressing OGT.
    Li F; Yang G; Tachikawa H; Shao K; Yang Y; Gao XD; Nakanishi H
    J Gen Appl Microbiol; 2021 Apr; 67(1):33-41. PubMed ID: 33229814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytosolic O-glycosylation is abundant in nerve terminals.
    Cole RN; Hart GW
    J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Centrosomes: Til O-GlcNAc Do Us Apart.
    Yuan A; Tang X; Li J
    Front Endocrinol (Lausanne); 2020; 11():621888. PubMed ID: 33597927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutrient regulation of signaling and transcription.
    Hart GW
    J Biol Chem; 2019 Feb; 294(7):2211-2231. PubMed ID: 30626734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series.
    Golks A; Guerini D
    EMBO Rep; 2008 Aug; 9(8):748-53. PubMed ID: 18617890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.